8-K

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date of Report: February 27, 2022

KaivalBrands Innovations Group, Inc.

(Exact name of registrant as specified in its charter)

4460Old Dixie Highway

Grant,Florida 32949

(Address of principal executive office, including zip code)

Telephone:(833) 452-4825

(Registrant’s telephone number, including area code)

Securities

registered pursuant to Section 12(b) of the Act:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

On February 27, 2022, the Compensation Committee (the “Committee”) and the Board of Directors (the “Board”) of Kaival Brands Innovations Group, Inc. (the “Company,” “we,” “us,” or “our”) approved the grant of a stock option award (the “Option”) to Mark Thoenes, Interim Chief Financial Officer, to acquire up to 100,000 shares (the “Option Shares”) of the Company’s common stock under the Company’s 2020 Stock and Incentive Compensation Plan. The Option Shares are exercisable at a price of $2.45 per share, which equals the closing price of the Company’s common stock as of the date immediately prior to the grant date. At the grant date, 50,000 Option Shares became immediately vested, with the remaining 50,000 Option Shares vesting on the one-year anniversary of the grant date. The Option has a ten-year term.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.